(Q68100404)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference

K. Mross

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568293

9 October 2022

K. Hamm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568293

9 October 2022

W. Schultze-Seemann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568293

9 October 2022

K. Burk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568293

9 October 2022

D. K. Hossfeld

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568293

9 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1568293

9 October 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

21 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

490-494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00684854

21 September 2019

exact match

0 references

cites work

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

1 reference

12 December 2020

The biology and treatment of superficial bladder cancer

1 reference

12 December 2020

Absorption of anticancer drugs through bladder epithelium

1 reference

12 December 2020

Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resectio

1 reference

12 December 2020

High-performance liquid chromatography of iodo-doxorubicin and fluorescent metabolites in plasma samples

1 reference

12 December 2020

Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies

1 reference

12 December 2020

Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview

1 reference

12 December 2020

Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients

1 reference

12 December 2020

Intravesical interferon treatment of superficial bladder cancer

1 reference

12 December 2020

Intravesical instillation of doxorubicin hydrochloride and its incorporation into bladder tumors

1 reference

12 December 2020

Studies on the intravesical action of topically administered G3H-doxorubicin hydrochloride in men: plasma uptake and tumor penetration

1 reference

12 December 2020

New method for the determination of doxorubicin, 4'-epidoxorubicin and all known metabolites in cardiac tissue

1 reference

12 December 2020

Optimal management of superficial bladder cancer

1 reference

12 December 2020

Absorption of epi-doxorubicin after intravesical administration in patients with in situ transitional cell carcinoma of the bladder

1 reference

12 December 2020

Idarubicin v daunorubicin: preclinical and clinical pharmacokinetic studies

1 reference

12 December 2020

Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours

1 reference

12 December 2020

Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00684854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568293%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference